Metethoheptazine

Last updated
Metethoheptazine
Metethoheptazine structure.png
Metethoheptazine-3D-balls.png
Clinical data
Other namesWY-535
ATC code
  • none
Identifiers
  • ethyl 1,3-dimethyl-4-phenylazepane-4-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula C17H25NO2
Molar mass 275.392 g·mol−1
3D model (JSmol)
  • O=C(OCC)C2(c1ccccc1)CCCN(C)CC2C
  • InChI=1S/C17H25NO2/c1-4-20-16(19)17(15-9-6-5-7-10-15)11-8-12-18(3)13-14(17)2/h5-7,9-10,14H,4,8,11-13H2,1-3H3 Yes check.svgY
  • Key:BOSULDNQDJLKKL-UHFFFAOYSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Metethoheptazine [1] (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s. [2]

Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States. [3] The Canadian Controlled Drugs and Substances Act specifically excludes phenazepine opioids from control.

References

  1. GB 843924,"Substituted azacycloheptanes", assigned to American Home Products
  2. Walkenstein SS, Corradino RA, Wiser R, Gudmundsen CH (February 1965). "Metabolism of the Non-Narcotic Analgesic, WY-5355". Biochemical Pharmacology. 14 (2): 121–8. doi:10.1016/0006-2952(65)90067-5. PMID   14332457.
  3. "Conversion Factors for Controlled Substances". Diversion Control Division. Drug Enforcement Administration, U.S. Department of Justice. Retrieved 8 October 2018.